Clinical Trials

NCT03418818 | ACTIVE_NOT_RECRUITING | NA
70 participants

FAZA PET/MRI Sarcoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-10
Start Date:
2018-03-27
Completion:
2028-10-31
Conditions
  • Sarcoma
Interventions
  • DRUG
No Results Yet
NCT03383575 | RECRUITING | PHASE2
63 participants

Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-10
Start Date:
2018-01-17
Completion:
2027-02-28
Conditions
  • Acute Myeloid Leukemia
  • Blasts 20-30 Percent of Bone Marrow Nucleated Cells
  • Chronic Myelomonocytic Leukemia
  • IDH2 Gene Mutation
  • Myelodysplastic Syndrome With Excess Blasts
  • Recurrent High Risk Myelodysplastic Syndrome
  • Refractory High Risk Myelodysplastic Syndrome
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT03253172 | ACTIVE_NOT_RECRUITING | NA
532 participants

Potassium Supplementation in CKD

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-10
Start Date:
2017-07-01
Completion:
2026-09-01
Conditions
  • Renal Insufficiency, Chronic
  • Potassium Depletion
  • Hypertension
  • Hyperkalemia
Interventions
  • DIETARY_SUPPLEMENT
No Results Yet
NCT03147612 | ACTIVE_NOT_RECRUITING | PHASE2
22 participants

Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-10
Start Date:
2018-02-08
Completion:
2027-02-28
Conditions
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia With BCR-ABL1
  • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Recurrent Acute Lymphoblastic Leukemia
  • Refractory Acute Lymphoblastic Leukemia
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT03136146 | RECRUITING | PHASE2
42 participants

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-10
Start Date:
2017-08-09
Completion:
2027-08-01
Conditions
  • Recurrent Acute Lymphoblastic Leukemia
  • Recurrent Adult Lymphoblastic Lymphoma
  • Recurrent Burkitt Leukemia
  • Recurrent Burkitt Lymphoma
  • Recurrent Childhood Lymphoblastic Lymphoma
  • Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
  • Refractory Acute Lymphoblastic Leukemia
  • Refractory Burkitt Leukemia
  • Refractory Burkitt Lymphoma
  • Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
  • Refractory Lymphoblastic Lymphoma
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT02955290 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
51 participants

CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-10
Start Date:
2016-12-22
Completion:
2026-11-25
Conditions
  • Advanced Head and Neck Squamous Cell Carcinoma
  • Lung Non-Small Cell Carcinoma
  • Metastatic Lung Non-Small Cell Carcinoma
  • PD-L1 Positive
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
  • Stage III Lung Cancer AJCC v8
  • Stage IIIA Lung Cancer AJCC v8
  • Stage IIIB Lung Cancer AJCC v8
  • Stage IIIC Lung Cancer AJCC v8
  • Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
  • Stage IV Lung Cancer AJCC v8
  • Stage IVA Lung Cancer AJCC v8
  • Stage IVB Lung Cancer AJCC v8
  • Unresectable Lung Non-Small Cell Carcinoma
  • Advanced Squamous Non-Small Cell Lung Carcinoma
Interventions
  • OTHER
  • BIOLOGICAL
No Results Yet
NCT02846623 | ACTIVE_NOT_RECRUITING | PHASE2
50 participants

Atezolizumab, Obinutuzumab, and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Relapsed or Refractory Richter Syndrome

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-10
Start Date:
2017-01-31
Completion:
2027-02-28
Conditions
  • Chronic Lymphocytic Leukemia
  • Recurrent Transformed Chronic Lymphocytic Leukemia
  • Refractory Transformed Chronic Lymphocytic Leukemia
  • Richter Syndrome
  • Small Lymphocytic Lymphoma
Interventions
  • DRUG
  • OTHER
  • BIOLOGICAL
No Results Yet
NCT02317328 | RECRUITING
1000 participants

Adaptive Optics Retinal Imaging

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-10
Start Date:
2015-02-20
Completion:
2028-03-31
Conditions
  • Eye Diseases
  • Healthy Volunteers
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page